UCB SA
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| UCBJY | ROIV | JAZZ | TGTX | ZLAB | LGND | |
|---|---|---|---|---|---|---|
| Market cap | 43.58B | 24.22B | 13.65B | 8.26B | 2.60B | 5.89B |
| P/E (TTM) | 17.3 | — | 14.4 | 19.6 | — | 31.1 |
| Forward P/E | 15.0 | -19.5 | 8.1 | 19.9 | -11.0 | 24.7 |
| Price/book | 3.3 | 5.7 | 2.8 | 12.7 | 4.3 | 6.1 |
| Dividend yield | 0.74% | — | — | — | — | — |
| 1-year change | −20.89% | +89.01% | +55.90% | +53.67% | −19.31% | +58.26% |
| Today | −0.87% | −1.50% | −1.95% | −3.63% | −1.36% | −0.99% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All UCBJY news ›UCB announces U.S. FDA approval for ZILBRYSQ® (zilucoplan) autoinjector self-administration for adults living with generalized myasthenia gravis
The ZILBRYSQ autoinjector is designed to automatically deliver a pre-defined dose when activated against the skin.1,2 Prior to the autoinjector's approval, ZILBRYSQ was available as a self-administered prefilled syringe (PFS). Patients or…
UCB Launches ‘Wear It Out’ Campaign for People Living With HS, PsO and PsA: Here’s What to Know
The Dermatology Digest UCB Launches ‘Wear It Out’ Campaign for People Living With HS, PsO and PsA: Here’s What to Know Developed alongside patient advocates and artist Sophia Yeshi, the Wear It Out program showcases the everyday, often…
UCB holds RMG conclave to promote sustainable industry
The United Commercial Bank PLC (UCB) recently organised a business conclave with senior garment and textile industry representatives to promote export competitiveness, energy security and sustainability challenges facing the sector. The…
UCB launches Brocks as part of £15m hospitality plan
20 October 2026 , 8:00 - 12:00 19 November 2026 , 8:00 - 12:00 2 December 2026 , 12:30 - 3:00 28 January 2027 , 8:00 - 12:00 4 February 2027 , 8:30 - 6:30 11 February 2027 , 12:30 - 3:30 22 April 2027 , 8:30 - 6:30 18 May 2027 , 8:30 -…
UCB (UCB) Gets FDA OK for ZILBRYSQ Autoinjector; US Launch Expected Q1 2027
TradingView UCB (UCB) Gets FDA OK for ZILBRYSQ Autoinjector; US Launch Expected Q1 2027 UCB received U.S. FDA approval for a once-daily ZILBRYSQ (zilucoplan) autoinjector for AChR+ adult gMG, adding a self-admin option to the existing PFS.…
FDA green light for UCB and positive view from DB
Belgian biopharmaceutical group UCB has announced that the US FDA has approved a new administration option for Zilbrysq (zilucoplan), its treatment for generalized myasthenia gravis in adult patients with anti-acetylcholine receptor (AChR)…
UCB hosts RMG Business Conclave 2026 to promote a competitive and sustainable industry
United Commercial Bank PLC (UCB) organised the UCB RMG Business Conclave 2026 at The Westin Dhaka on October 13, bringing together senior executives and industry representatives from the ready-made garment (RMG) and textile sectors. Held…
UCB Dedicates Future U.S. Biologics Manufacturing Campus in Georgia
~330 jobs to be based at $2B, ~460,000-square-foot campus in Gwinnett County A rendering of the Rowen, GA, site where UCB plans to build a $2 billion biologics manufacturing campus that is set to open as the Belgian-based drug developer’s…
UCB Launches Wear It Out, a Community-Driven Program Created For and With People Living With Hidradenitis Suppurativa, Plaque Psoriasis, and Psoriatic Arthritis
PR Newswire - The Wear It Out program was created with and for patient advocates to reduce stigma and increase awareness of the everyday, often unseen compromises and decisions people make because of their conditions. - Artist Sophia Yeshi…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com4
-
thedailystar.net3
-
dazzlingdawn.com2
-
indianpharmapost.com2
-
marketscreener.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 39 articles, not a forecast.